biotecture limited
biotecture limited Company Information
Company Number
06297364
Next Accounts
Dec 2025
Shareholders
mitie landscapes limited
Group Structure
View All
Industry
Specialised design activities
Registered Address
level 12, the shard, 32 london bridge street, london, SE1 9SG
Website
www.biotecture.uk.combiotecture limited Estimated Valuation
Pomanda estimates the enterprise value of BIOTECTURE LIMITED at £2.4m based on a Turnover of £5m and 0.48x industry multiple (adjusted for size and gross margin).
biotecture limited Estimated Valuation
Pomanda estimates the enterprise value of BIOTECTURE LIMITED at £3.6m based on an EBITDA of £898k and a 3.98x industry multiple (adjusted for size and gross margin).
biotecture limited Estimated Valuation
Pomanda estimates the enterprise value of BIOTECTURE LIMITED at £3.6m based on Net Assets of £2m and 1.85x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biotecture Limited Overview
Biotecture Limited is a live company located in london, SE1 9SG with a Companies House number of 06297364. It operates in the specialised design activities sector, SIC Code 74100. Founded in June 2007, it's largest shareholder is mitie landscapes limited with a 100% stake. Biotecture Limited is a established, small sized company, Pomanda has estimated its turnover at £5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biotecture Limited Health Check
Pomanda's financial health check has awarded Biotecture Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
3 Regular
2 Weak
Size
annual sales of £5m, make it larger than the average company (£194.9k)
£5m - Biotecture Limited
£194.9k - Industry AVG
Growth
3 year (CAGR) sales growth of 62%, show it is growing at a faster rate (13.4%)
- Biotecture Limited
13.4% - Industry AVG
Production
with a gross margin of 48.3%, this company has a comparable cost of product (48.4%)
48.3% - Biotecture Limited
48.4% - Industry AVG
Profitability
an operating margin of 17.6% make it more profitable than the average company (8.7%)
17.6% - Biotecture Limited
8.7% - Industry AVG
Employees
with 39 employees, this is above the industry average (2)
39 - Biotecture Limited
2 - Industry AVG
Pay Structure
on an average salary of £42.1k, the company has a higher pay structure (£31.2k)
£42.1k - Biotecture Limited
£31.2k - Industry AVG
Efficiency
resulting in sales per employee of £127.5k, this is more efficient (£100.3k)
£127.5k - Biotecture Limited
£100.3k - Industry AVG
Debtor Days
it gets paid by customers after 75 days, this is near the average (70 days)
75 days - Biotecture Limited
70 days - Industry AVG
Creditor Days
its suppliers are paid after 52 days, this is slower than average (38 days)
52 days - Biotecture Limited
38 days - Industry AVG
Stock Days
it holds stock equivalent to 31 days, this is in line with average (35 days)
31 days - Biotecture Limited
35 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 16 weeks, this is less cash available to meet short term requirements (25 weeks)
16 weeks - Biotecture Limited
25 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 32.8%, this is a lower level of debt than the average (59.3%)
32.8% - Biotecture Limited
59.3% - Industry AVG
BIOTECTURE LIMITED financials
Biotecture Limited's latest turnover from March 2024 is £5 million and the company has net assets of £2 million. According to their latest financial statements, Biotecture Limited has 39 employees and maintains cash reserves of £296 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4,973,000 | 5,541,000 | |||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 2,571,000 | 3,243,000 | |||||||||||||
| Gross Profit | 2,402,000 | 2,298,000 | |||||||||||||
| Admin Expenses | 1,526,000 | 2,066,000 | |||||||||||||
| Operating Profit | 876,000 | 232,000 | |||||||||||||
| Interest Payable | 1,000 | 4,000 | |||||||||||||
| Interest Receivable | 13,000 | 1,000 | |||||||||||||
| Pre-Tax Profit | 888,000 | 229,000 | |||||||||||||
| Tax | -172,000 | -45,000 | |||||||||||||
| Profit After Tax | 716,000 | 184,000 | |||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | 716,000 | 184,000 | |||||||||||||
| Employee Costs | 1,642,000 | 2,193,000 | |||||||||||||
| Number Of Employees | 39 | 39 | 33 | 36 | 32 | 32 | 28 | 17 | |||||||
| EBITDA* | 898,000 | 265,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 43,000 | 60,000 | 202,414 | 213,559 | 215,990 | 68,550 | 62,528 | 89,219 | 97,326 | 12,143 | 11,104 | 12,622 | 3,776 | 2,629 | 1,890 |
| Intangible Assets | 25,000 | 30,000 | 45,187 | 45,318 | 29,546 | 5,320 | 885 | 951 | 728 | 780 | 832 | 884 | 936 | 988 | |
| Investments & Other | 101 | 101 | 101 | 101 | 101 | ||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 68,000 | 90,000 | 247,601 | 258,877 | 245,637 | 73,971 | 63,514 | 90,271 | 98,155 | 12,923 | 11,936 | 13,506 | 4,712 | 3,617 | 1,890 |
| Stock & work in progress | 221,000 | 188,000 | 185,585 | 163,790 | 146,640 | 84,704 | 83,468 | 90,956 | 92,000 | 25,000 | 10,500 | 7,000 | 7,000 | 7,000 | 3,474 |
| Trade Debtors | 1,031,000 | 537,000 | 440,105 | 345,087 | 297,034 | 471,334 | 447,644 | 446,252 | 522,870 | 287,280 | 303,678 | 155,246 | 120,583 | 40,091 | 45,436 |
| Group Debtors | 509,000 | 271,752 | 86,677 | ||||||||||||
| Misc Debtors | 776,000 | 520,000 | 258,263 | 467,797 | 500,730 | 380,746 | 129,975 | 33,349 | |||||||
| Cash | 296,000 | 559,000 | 523,111 | 708,048 | 574,546 | 420,542 | 317,236 | 267,614 | 314,282 | 246,343 | 10,285 | 49,507 | 68,501 | 28,237 | 39,939 |
| misc current assets | |||||||||||||||
| total current assets | 2,833,000 | 1,804,000 | 1,678,816 | 1,771,399 | 1,518,950 | 1,357,326 | 978,323 | 838,171 | 929,152 | 558,623 | 324,463 | 211,753 | 196,084 | 75,328 | 88,849 |
| total assets | 2,901,000 | 1,894,000 | 1,926,417 | 2,030,276 | 1,764,587 | 1,431,297 | 1,041,837 | 928,442 | 1,027,307 | 571,546 | 336,399 | 225,259 | 200,796 | 78,945 | 90,739 |
| Bank overdraft | 125,000 | 10,417 | |||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 368,000 | 180,000 | 230,297 | 245,587 | 555,409 | 481,611 | 246,299 | 186,428 | 434,779 | 313,777 | 166,979 | 94,001 | 157,992 | 62,335 | 90,171 |
| Group/Directors Accounts | 67,000 | 226,000 | 100 | 100 | 100 | ||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | 1,000 | 7,000 | 32,715 | 27,000 | |||||||||||
| other current liabilities | 509,000 | 247,000 | 284,865 | 544,886 | 285,647 | 259,632 | 155,754 | 122,216 | |||||||
| total current liabilities | 945,000 | 660,000 | 672,877 | 827,890 | 841,056 | 741,343 | 402,153 | 308,744 | 434,779 | 313,777 | 166,979 | 94,001 | 157,992 | 62,335 | 90,171 |
| loans | 104,167 | 239,583 | |||||||||||||
| hp & lease commitments | 81,048 | 101,250 | |||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 5,000 | 9,000 | 27,700 | 9,300 | 1,700 | 2,100 | 8,600 | 5,300 | 2,400 | 2,500 | |||||
| total long term liabilities | 5,000 | 9,000 | 212,915 | 340,833 | 9,300 | 1,700 | 2,100 | 8,600 | 5,300 | 2,400 | 2,500 | ||||
| total liabilities | 950,000 | 669,000 | 885,792 | 1,168,723 | 850,356 | 743,043 | 404,253 | 317,344 | 440,079 | 316,177 | 166,979 | 96,501 | 157,992 | 62,335 | 90,171 |
| net assets | 1,951,000 | 1,225,000 | 1,040,625 | 861,553 | 914,231 | 688,254 | 637,584 | 611,098 | 587,228 | 255,369 | 169,420 | 128,758 | 42,804 | 16,610 | 568 |
| total shareholders funds | 1,951,000 | 1,225,000 | 1,040,625 | 861,553 | 914,231 | 688,254 | 637,584 | 611,098 | 587,228 | 255,369 | 169,420 | 128,758 | 42,804 | 16,610 | 568 |
| Mar 2024 | Mar 2023 | Oct 2021 | Oct 2020 | Oct 2019 | Oct 2018 | Oct 2017 | Oct 2016 | Oct 2015 | Oct 2014 | Oct 2013 | Oct 2012 | Oct 2011 | Oct 2010 | Oct 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 876,000 | 232,000 | |||||||||||||
| Depreciation | 17,000 | 27,000 | 36,582 | 8,583 | 20,179 | 22,857 | 19,073 | 27,016 | 32,473 | 4,025 | 3,692 | 4,214 | 1,294 | 952 | 613 |
| Amortisation | 5,000 | 6,000 | 9,391 | 6,355 | 774 | 565 | 66 | 67 | 52 | 52 | 52 | 52 | 52 | 52 | |
| Tax | -172,000 | -45,000 | |||||||||||||
| Stock | 33,000 | 188,000 | 21,795 | 17,150 | 61,936 | 1,236 | -7,488 | -1,044 | 67,000 | 14,500 | 3,500 | 3,526 | 3,474 | ||
| Debtors | 1,259,000 | 1,057,000 | 70,559 | 101,797 | -54,316 | 274,461 | 98,018 | -43,269 | 235,590 | -16,398 | 148,432 | 34,663 | 80,492 | -5,345 | 45,436 |
| Creditors | 188,000 | 180,000 | -15,290 | -309,822 | 73,798 | 235,312 | 59,871 | -248,351 | 121,002 | 146,798 | 72,978 | -63,991 | 95,657 | -27,836 | 90,171 |
| Accruals and Deferred Income | 262,000 | 247,000 | -260,021 | 259,239 | 26,015 | 103,878 | 33,538 | 122,216 | |||||||
| Deferred Taxes & Provisions | -4,000 | 9,000 | 27,700 | -9,300 | 7,600 | -400 | -6,500 | 3,300 | 2,900 | 2,400 | -2,500 | 2,500 | |||
| Cash flow from operations | -120,000 | -589,000 | |||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | -101 | 101 | |||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -159,000 | 226,000 | -100 | 100 | |||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -135,416 | 239,583 | |||||||||||||
| Hire Purchase and Lease Commitments | -6,000 | 7,000 | -14,487 | 128,250 | |||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 12,000 | -3,000 | |||||||||||||
| cash flow from financing | -143,000 | 1,271,000 | |||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -263,000 | 559,000 | -184,937 | 133,502 | 154,004 | 103,306 | 49,622 | -46,668 | 67,939 | 236,058 | -39,222 | -18,994 | 40,264 | -11,702 | 39,939 |
| overdraft | 114,583 | 10,417 | |||||||||||||
| change in cash | -263,000 | 559,000 | -299,520 | 123,085 | 154,004 | 103,306 | 49,622 | -46,668 | 67,939 | 236,058 | -39,222 | -18,994 | 40,264 | -11,702 | 39,939 |
biotecture limited Credit Report and Business Information
Biotecture Limited Competitor Analysis
Perform a competitor analysis for biotecture limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in SE1 area or any other competitors across 12 key performance metrics.
biotecture limited Ownership
BIOTECTURE LIMITED group structure
Biotecture Limited has 1 subsidiary company.
Ultimate parent company
2 parents
BIOTECTURE LIMITED
06297364
1 subsidiary
biotecture limited directors
Biotecture Limited currently has 4 directors. The longest serving directors include Mr Peter Dickinson (Jan 2022) and Mr Timothy Howell (Jan 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Peter Dickinson | England | 63 years | Jan 2022 | - | Director |
| Mr Timothy Howell | 57 years | Jan 2022 | - | Director | |
| Mr Matthew Peacock | England | 54 years | Jan 2022 | - | Director |
| Mr Peter Dickinson | England | 63 years | Jan 2022 | - | Director |
P&L
March 2024turnover
5m
-10%
operating profit
876k
+278%
gross margin
48.4%
+16.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
2m
+0.59%
total assets
2.9m
+0.53%
cash
296k
-0.47%
net assets
Total assets minus all liabilities
biotecture limited company details
company number
06297364
Type
Private limited with Share Capital
industry
74100 - Specialised design activities
incorporation date
June 2007
age
18
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
level 12, the shard, 32 london bridge street, london, SE1 9SG
Bank
-
Legal Advisor
-
biotecture limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to biotecture limited. Currently there are 0 open charges and 3 have been satisfied in the past.
biotecture limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOTECTURE LIMITED. This can take several minutes, an email will notify you when this has completed.
biotecture limited Companies House Filings - See Documents
| date | description | view/download |
|---|
